DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announceDALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country.

The opening of more and more AICC sites highlights AIC’s strategic dedication to addressing the rising demand for outpatient infusion therapy. Designed based on a modern, patient-focused approach, the Centers emphasize comfort, convenience, and clinical excellence. Now accepting referrals, the Marietta location is ready to deliver individualized infusion therapy to the patients who depend on these services in the greater Atlanta region.

“We are truly excited to open our new infusion Center in Marietta, GA as it represents another meaningful step in our mission to bring high-quality, personalized care closer to the patients who need it most,” said Simon Castellanos, CEO of AIS Healthcare. “This expansion allows us to better support the community while continuing to raise the standard for outpatient infusion services nationwide.”

Offering a wide range of therapies for both long-term and short-term conditions, AICC—including the Marietta location—ensure that patients have access to the newest FDA-approved treatments. The Centers are built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. In Marietta, patients will find private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.

“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”

As a full-service partner to clinicians, AIC works collaboratively with provider offices, insurance companies, and patients to secure all required authorizations and approvals. Dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC) further sets AIC apart as a trusted leader in infusion care.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Jud Hall

877.443.4006

Market Opportunity
AI COMPANIONS Logo
AI COMPANIONS Price(AIC)
$0.078056
$0.078056$0.078056
-2.80%
USD
AI COMPANIONS (AIC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

The post Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment? appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 17:39 Is dogecoin really fading? As traders hunt the best crypto to buy now and weigh 2025 picks, Dogecoin (DOGE) still owns the meme coin spotlight, yet upside looks capped, today’s Dogecoin price prediction says as much. Attention is shifting to projects that blend culture with real on-chain tools. Buyers searching “best crypto to buy now” want shipped products, audits, and transparent tokenomics. That frames the true matchup: dogecoin vs. Pepeto. Enter Pepeto (PEPETO), an Ethereum-based memecoin with working rails: PepetoSwap, a zero-fee DEX, plus Pepeto Bridge for smooth cross-chain moves. By fusing story with tools people can use now, and speaking directly to crypto presale 2025 demand, Pepeto puts utility, clarity, and distribution in front. In a market where legacy meme coin leaders risk drifting on sentiment, Pepeto’s execution gives it a real seat in the “best crypto to buy now” debate. First, a quick look at why dogecoin may be losing altitude. Dogecoin Price Prediction: Is Doge Really Fading? Remember when dogecoin made crypto feel simple? In 2013, DOGE turned a meme into money and a loose forum into a movement. A decade on, the nonstop momentum has cooled; the backdrop is different, and the market is far more selective. With DOGE circling ~$0.268, the tape reads bearish-to-neutral for the next few weeks: hold the $0.26 shelf on daily closes and expect choppy range-trading toward $0.29–$0.30 where rallies keep stalling; lose $0.26 decisively and momentum often bleeds into $0.245 with risk of a deeper probe toward $0.22–$0.21; reclaim $0.30 on a clean daily close and the downside bias is likely neutralized, opening room for a squeeze into the low-$0.30s. Source: CoinMarketcap / TradingView Beyond the dogecoin price prediction, DOGE still centers on payments and lacks native smart contracts; ZK-proof verification is proposed,…
Share
BitcoinEthereumNews2025/09/18 00:14
Liquidity Boost Stabilizes Solana-Based Stablecoin USX After Market Drop

Liquidity Boost Stabilizes Solana-Based Stablecoin USX After Market Drop

Solana's USX stablecoin experiences a significant market drop due to liquidity issues. Solstice Finance intervenes to stabilize the value.Read more...
Share
Coinstats2025/12/27 12:51
3 Paradoxes of Altcoin Season in September

3 Paradoxes of Altcoin Season in September

The post 3 Paradoxes of Altcoin Season in September appeared on BitcoinEthereumNews.com. Analyses and data indicate that the crypto market is experiencing its most active altcoin season since early 2025, with many altcoins outperforming Bitcoin. However, behind this excitement lies a paradox. Most retail investors remain uneasy as their portfolios show little to no profit. This article outlines the main reasons behind this situation. Altcoin Market Cap Rises but Dominance Shrinks Sponsored TradingView data shows that the TOTAL3 market cap (excluding BTC and ETH) reached a new high of over $1.1 trillion in September. Yet the share of OTHERS (excluding the top 10) has declined since 2022, now standing at just 8%. OTHERS Dominance And TOTAL3 Capitalization. Source: TradingView. In past cycles, such as 2017 and 2021, TOTAL3 and OTHERS.D rose together. That trend reflected capital flowing not only into large-cap altcoins but also into mid-cap and low-cap ones. The current divergence shows that capital is concentrated in stablecoins and a handful of top-10 altcoins such as SOL, XRP, BNB, DOG, HYPE, and LINK. Smaller altcoins receive far less liquidity, making it hard for their prices to return to levels where investors previously bought. This creates a situation where only a few win while most face losses. Retail investors also tend to diversify across many coins instead of adding size to top altcoins. That explains why many portfolios remain stagnant despite a broader market rally. Sponsored “Position sizing is everything. Many people hold 25–30 tokens at once. A 100x on a token that makes up only 1% of your portfolio won’t meaningfully change your life. It’s better to make a few high-conviction bets than to overdiversify,” analyst The DeFi Investor said. Altcoin Index Surges but Investor Sentiment Remains Cautious The Altcoin Season Index from Blockchain Center now stands at 80 points. This indicates that over 80% of the top 50 altcoins outperformed…
Share
BitcoinEthereumNews2025/09/18 01:43